Delivery Order SPE2DR25D3103-SPE2DR26F9F47
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $24,305.05 by the Defense Logistics Agency on August 28, 2025, for the supply of Abilify Maintena ER 400 mg syringes. The contract is firm fixed price with an ultimate completion date of August 29, 2025, and represents a competitive award with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,684.34 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. This firm fixed-price contract, awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a non-set-aside competitive procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,842.17 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. This firm fixed price delivery order was competitively awarded without set-aside designation and is set for completion by August 13, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Abilify Maintena ER 400 mg vials/syringes with a ceiling value of $1,784.28. This firm fixed-price delivery order, with an ultimate completion date of November 14, 2025, represents a continuation of pharmaceutical support under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order valued at $16,592.44 to AmerisourceBergen Drug Corp for Abilify Maintena ER 400 mg vials on November 12, 2025, with completion scheduled for November 13, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Abilify Maintena is a long-acting antipsychotic medication used in the treatment of...
- The Defense Logistics Agency awarded a delivery order valued at $1,842.17 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. This firm fixed price contract, awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a competitively awarded, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,152.56 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. The order is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of November 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes on October 27, 2025, with a ceiling value of $2,141.05 and an ultimate completion date of October 28, 2025. This non-competitive delivery order represents a firm fixed price procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00...
- The Defense Logistics Agency awarded a $4,531.06 delivery order to AmerisourceBergen Drug Corp for Abilify Maintena ER 400 mg syringes, with an ultimate completion date of September 12, 2025. This is a firm fixed price contract with no set-aside designation, awarded on a competitive basis. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,842.17 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. This competitively awarded, firm fixed-price delivery order was issued on October 16, 2025, with an ultimate completion date of October 17, 2025. The award carries no set-aside designation, indicating open competition among qualified vendors. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9F47Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $13,697.48 to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Abilify Maintena ER 400 mg vials/cartridges/syringes. This firm fixed-price, competitively awarded delivery order represents a non-set-aside procurement and is scheduled for completion by November 14, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's distribution hub for federal pharmaceutical procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. As a premier pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems with a comprehensive range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The procurement of Abilify Maintena ER, an atypical antipsychotic medication for psychiatric treatment, supports military and veteran healthcare program requirements through DLA's established pharmaceutical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.7k | 11/13/25 |